NSF has posted an advisory announcing a release of updates to FastLane on January 30th, 2017. These changes to FastLane will support the NSF policy updates that will be effective for proposals submitted, or due, on or after January 30th, 2017.
On Thursday, January 12th at 7pm, GMAS will become unavailable for a stabilization release. This release addresses bug fixes identified immediately after the December release, as well as some additional changes. These fixes and changes include:
The Uniform Guidance, specifically §200.331, requires pass-through entities to evaluate each subrecipient's risk of noncompliance in order to determine the appropriate monitoring level and to monitor the activities of subrecipient organizations to ensure that the subaward is in compliance with applicable Federal statutes and regulations and the terms of the subaward.
In September Dr. Carrie Wolinetz and I blogged about our policy reforms to build a more robust clinical trials enterprise through greater stewardship and transparency at each phase of the clinical trial journey from conception to sharing of results. We discussed how these efforts promise to improve the quality and efficiency of clinical trials, translating into more innovative and robust clinical trial design, and accelerated discoveries that will advance human health. Read more about Status of Our Initiatives to Strengthen Clinical Trials